Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04541563 · ClinicalTrials.gov registry record · NA
Fisher Wallace Neurostimulation & Depression Study
A NA study of Major Depressive Disorder, sponsored by ProofPilot.
- Active
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 1
- Study location
NCT04541563: Active NA study of Major Depressive Disorder, sponsored by ProofPilot.
NCT04541563 is a NA study of Major Depressive Disorder that is active but no longer recruiting, run by ProofPilot. The registered enrollment target is 175 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04541563, a NA study of Major Depressive Disorder, is active but no longer recruiting, sponsored by ProofPilot.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.
Primary Outcome
Change in depression symptoms from baseline to treatment week 4 in immediate versus delayed arm. Lower scores show improvement in depression symptoms.
Conditions Studied
Interventions
- DEVICE Fisher Wallace Cranial Electrotherapy Stimulator Device
Study Locations (1)
New York
- ProofPilot (Remote Virtual Trial) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2021-11-30 |
| Phase | NA |
What the registry record for NCT04541563 still lists
NCT04541563 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Fisher Wallace Cranial Electrotherapy Stimulator Device is the first listed.
NCT04541563 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04541563 about?
NCT04541563 is a clinical study titled "Fisher Wallace Neurostimulation & Depression Study". Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.
What is the current status of trial NCT04541563?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2020-08-24. Estimated completion is 2021-11-30.
What conditions does trial NCT04541563 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT04541563?
The interventions under investigation include: Fisher Wallace Cranial Electrotherapy Stimulator Device (DEVICE).
Who is sponsoring clinical trial NCT04541563?
This trial is sponsored by ProofPilot, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04541563 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04541563's enrollment target sits among peer trials
175 87th of 282 higher than 196 of 282 other Major Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI